4.4 Article

Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis

期刊

BMC NEUROLOGY
卷 13, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/1471-2377-13-37

关键词

-

资金

  1. Biogen Idec
  2. Multiple Sclerosis International Federation

向作者/读者索取更多资源

Background: The Patient Determined Disease Steps (PDDS) is a promising patient-reported outcome (PRO) of disability in multiple sclerosis (MS). To date, there is limited evidence regarding the validity of PDDS scores, despite its sound conceptual development and broad inclusion in MS research. This study examined the validity of the PDDS based on (1) the association with Expanded Disability Status Scale (EDSS) scores and (2) the pattern of associations between PDDS and EDSS scores with Functional System (FS) scores as well as ambulatory and other outcomes. Methods: 96 persons with MS provided demographic/clinical information, completed the PDDS and other PROs including the Multiple Sclerosis Walking Scale-12 (MSWS-12), and underwent a neurological examination for generating FS and EDSS scores. Participants completed assessments of cognition, ambulation including the 6-minute walk (6 MW), and wore an accelerometer during waking hours over seven days. Results: There was a strong correlation between EDSS and PDDS scores (rho = .783). PDDS and EDSS scores were strongly correlated with Pyramidal (rho = .578 & rho = .647, respectively) and Cerebellar (rho = .501 & rho = .528, respectively) FS scores as well as 6 MW distance (rho = .704 & rho = .805, respectively), MSWS-12 scores (rho = .801 & rho = .729, respectively), and accelerometer steps/day (rho = -.740 & rho = -.717, respectively). Conclusion: This study provides novel evidence supporting the PDDS as valid PRO of disability in MS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据